Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Short-term Investments: 2022-2024

Historic Short-term Investments for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $248.4 million.

  • Gossamer Bio's Short-term Investments fell 42.63% to $171.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $171.3 million, marking a year-over-year decrease of 42.63%. This contributed to the annual value of $248.4 million for FY2024, which is 6.00% down from last year.
  • Latest data reveals that Gossamer Bio reported Short-term Investments of $248.4 million as of FY2024, which was down 6.00% from $264.3 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Short-term Investments ranged from a high of $264.3 million in FY2023 and a low of $143.7 million during FY2022.
  • In the last 3 years, Gossamer Bio's Short-term Investments had a median value of $248.4 million in 2024 and averaged $218.8 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first skyrocketed by 83.93% in 2023, then fell by 6.00% in 2024.
  • Over the past 3 years, Gossamer Bio's Short-term Investments (Yearly) stood at $143.7 million in 2022, then soared by 83.93% to $264.3 million in 2023, then declined by 6.00% to $248.4 million in 2024.